Argentex Group, the currency management firm caught in the financial crossfire of Donald Trump's tariffs crusade, has rejected an effort to gatecrash its emergency sale to rival IFX Payments. The ...

The Company's poster, titled " Multicenter, randomized, double-blinded, placebo-controlled trial of IFx-Hu2.0 (IFx) as adjunctive therapy with pembrolizumab (pembro) in checkpoint inhibitor (CPI ...

In the Phase 1b trial of IFx-Hu2.0, MCC among patients who progressed on pembrolizumab (anti-PD-1) or avelumab (anti-PDL-1) therapy, weekly administration of IFx-Hu2.0 for up to 3 doses followed ...

From fxempire.com iFX EXPO International 2025 is fast approaching, and the global online trading community is already buzzing with anticipation. Taking place in Limassol, Cyprus from June 17-19, 2025, ...

From financemagnates.com Get ready to dive into the heart of the online trading world! iFX EXPO International 2025 is set to ignite the industry once again, bringing together the brightest minds and ...

A close call earlier this month at LaGuardia Airport in New York City between two commercial jets is under investigation, the Federal Aviation Administration and National Transportation Safety ...

Ground stops, delays reported at EWR, LGA and JFK: FAA says Just ahead of 2:30 p.m., JFK was said to be experiencing an average ground delay of 107 minutes due to weather.

TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immune-oncology company developing novel technologies to overcome resistance to cancer immunotherapy, today announced ...

The primary endpoint of the study is safety and feasibility of IFx-Hu2.0 adjuvant therapy evaluated 28 days following the last dose of IFx-Hu2.0, or Day 49 from the first IFx-Hu2.0 infusion.

IFX will pay 2.49 pence per share in the takeover deal, which values Argentex at near £3m. The company will also provide the AIM-listed firm with secured bridge funding of about £6.5m.

2.49 pence per share offer values Argentex at 3 million pounds * IFX also provides secured bridge funding of 6.5 million pounds * Argentex CEO steps down, COO Tim Rudman named interim CEO ...

UK-based IFX will pay 2.49 pence per Argentex share to acquire the company, valuing Argentex at about 3 million pounds ($4 million), the two companies said.